MarkosWebWeb intelligence for the agentic economy

PreDxion Bio

Inactive

Rapid, scalable diagnostic for SARS-CoV-2 and beyond

predxionbio.comAI readiness report

What it does

PreDxion Bio is working on a rapid saliva-based antigen test for the detection of SARS-CoV-2 S-protein in asymptomatic and presymptomatic patients. Our technology is uniquely capable of being scaled to 10's of millions of tests of days using semiconductor fab processes, a scale of testing necessary to better inform public health officials and policymakers and enable contact tracing at scale. PreDxion Bio's origins are in critical care: our original technology is a rapid, near real-time cytokine and biomarker detection platform to monitor the immune response of critically-ill patients. This technology leverages a novel sensor platform we spun out of the University of Michigan. PreDxion Bio has received FDA Breakthrough Device designation and partnered with top pharmcos to monitor the immune response following CAR-T therapy and predict the development of cytokine release syndrome and neurological AEs, and for use in guiding precision medicine approaches in critical care.

Next to it in Healthcare and bio · Rapid saliva-based diagnostic testing

  • Xtrava Inc.Plug and Play

    MicroLab Platform is an accurate low cost digital rapid testing solution for COVID-19.

  • Clip HealthY Combinator S16

    Testing & treatment at home, in minutes, for chronic & acute disease

  • AFI CorporationPlug and Play

    Development, manufacturing, and sales of devices,

  • TestCardPlug and Play

    TestCard enables an individual to take ownership of their health, making laboratory level information accessible and painless and thus enfranchising the individual and ultimately democratising healthcare.

  • LSK TechnologiesY Combinator S20

    A diagnostic lab in a box

  • Astek DiagnosticsY Combinator S21

    One-hour antibiotic sensitivity testing

  • VedaBioY Combinator S21

    CRISPR powered Diagnostics with results in minutes.

  • Fyodor Biotechnologies500 Global 500G GA 22

    Developer of a non-invasive malaria testing technology designed to deliver a simple system to major global health problems. The company's technology helps people with a fever to diagnose malaria using a few drops of urine instead of blood, enabling healthcare professionals to help patients diagnose malaria conveniently and minimize pain and blood loss.